LOX and hepatocellular carcinoma: found that TGFB‐mediated VEGF was downregulated in HCC cells, which was influenced by LOX through the p38/MAPK signaling pathway; in addition, LOX knockout in HCC cells suppressed the proliferation, migration, and invasion, and the expression of VEGF was declined [9].